The Maharashtra Food and Drug Administration (FDA) has ordered suspension of the manufacturing at the Mahad unit of Sequent Scientific for a period of 15 days, starting July 1 to July 15, 2016. The company is hopeful of getting the process completed in the next couple of days. In the meantime, the unit continues to operate and the company expects no business interruptions.
Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals.
